of the Core The Molecular Pathology and Imaging Core (MPIC) was established in 1995 as the """"""""Morphology Core,"""""""" as part of the Program Project """"""""Differentiation of Tissues Involved in Nutrition and Metabolism"""""""" (DK049210). In 1997, MPIC expanded to provide services and reagents to investigators (i.e. members and associate members) of the Center for Molecular Studies in Digestive and Liver Disease (CMSDLD;P30DK50306) and, in 2003, became part of an additional Program Project, """"""""Mechanisms of Esophageal Carcinogenesis"""""""" (CA098101). The additional funding through the CMSDLD and the second P01 allowed MPIC to grow significantly by expanding services, equipment, space, and personnel, with tremendous benefits, as detailed below, to CMSDLD investigators. The name change, instituted this year, reflects a marked expansion of Core services and equipment. Through the years. MPIC has remained independent, rather than become an open, school-wide facility, in order to preserve focus and serve the needs of its dedicated clientele. Thus, use of the facility is restricted to CMSDLD investigators and investigators of the two P01s. Currently, MPIC comprises 4 rooms and 1153 square feet (Figure 1) on the 6""""""""^ floor of the Clinical Research Building (CRB), adjacent to many of the GI research laboratories;a recent addition expanded the size of MPIC by more than 70%. MPIC now includes the following: ? two large laboratories (CRB 602 and 675) with 8 total benches and 2 chemical hoods, each containing a complete set-up for performing in-core immunohistochemistry (IHC), immunofluorescence (IF), and in-situ hybridization (ISH) ? a tissue processing room (CRB 61 OB) with a chemical hood ? an adjacent small room (CRB 608) housing the confocal microscope and laser capture micro-dissection (LCM) apparatus. ? office space (adjoining CRB 675) for the technical director with computer and telecommunications MPIC has been extremely successful since its inception, has been heavily utilized, and has served as a model core facility for numerous other program projects and centers both at the University of Pennsylvania and throughout the country. Moreover, MPIC has continually improved its ability to provide quality services in a timely manner to CMSDLD investigators. MPIC assesses nominal charges for tissue processing and sectioning, special staining, confocal microscopy, and laser capture microdissection;all other core services are available at no cost to CMSDLD investigators and their laboratories;MPIC services are particularly valuable to associate members, many of whom do not yet have independent funding, and Pilot and Feasibility (P/F) awardees. MPIC was reviewed recently through the competitive renewals of the two supporting P01 grants (P01 DK049210 was reviewed in 2008 and P01 DK049210 in 2011) and was judged to be exceptional in both cases. For example, in the most recent review in 2011

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
5P30DK050306-17
Application #
8441493
Study Section
Special Emphasis Panel (ZDK1-GRB-8)
Project Start
Project End
Budget Start
2013-07-01
Budget End
2014-06-30
Support Year
17
Fiscal Year
2013
Total Cost
$187,548
Indirect Cost
$70,330
Name
University of Pennsylvania
Department
Type
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Karakasheva, Tatiana A; Dominguez, George A; Hashimoto, Ayumi et al. (2018) CD38+ M-MDSC expansion characterizes a subset of advanced colorectal cancer patients. JCI Insight 3:
Uribe-Herranz, Mireia; Bittinger, Kyle; Rafail, Stavros et al. (2018) Gut microbiota modulates adoptive cell therapy via CD8? dendritic cells and IL-12. JCI Insight 3:
Facompre, Nicole D; Harmeyer, Kayla M; Sahu, Varun et al. (2018) Targeting JARID1B's demethylase activity blocks a subset of its functions in oral cancer. Oncotarget 9:8985-8998
Estrada, Michelle A; Zhao, Xiao; Lorent, Kristin et al. (2018) Synthesis and Structure-Activity Relationship Study of Biliatresone, a Plant Isoflavonoid That Causes Biliary Atresia. ACS Med Chem Lett 9:61-64
DeLong, Jonathan H; Hall, Aisling O'Hara; Konradt, Christoph et al. (2018) Cytokine- and TCR-Mediated Regulation of T Cell Expression of Ly6C and Sca-1. J Immunol 200:1761-1770
Williams, Bianca; Correnti, Jason; Oranu, Amanke et al. (2018) A novel role for ceramide synthase 6 in mouse and human alcoholic steatosis. FASEB J 32:130-142
Karakasheva, Tatiana A; Lin, Eric W; Tang, Qiaosi et al. (2018) IL-6 Mediates Cross-Talk between Tumor Cells and Activated Fibroblasts in the Tumor Microenvironment. Cancer Res 78:4957-4970
Bengsch, Bertram; Ohtani, Takuya; Herati, Ramin Sedaghat et al. (2018) Deep immune profiling by mass cytometry links human T and NK cell differentiation and cytotoxic molecule expression patterns. J Immunol Methods 453:3-10
Moreira, Leticia; Bakir, Basil; Chatterji, Priya et al. (2018) Pancreas 3D Organoids: Current and Future Aspects as a Research Platform for Personalized Medicine in Pancreatic Cancer. Cell Mol Gastroenterol Hepatol 5:289-298
Das, Koushik K; Heeg, Steffen; Pitarresi, Jason R et al. (2018) ETV5 regulates ductal morphogenesis with Sox9 and is critical for regeneration from pancreatitis. Dev Dyn 247:854-866

Showing the most recent 10 out of 700 publications